Immunohistochemical characterization of transgenic mice highly expressing human lysosomal alpha-galactosidase. 1998

R Kase, and M Shimmoto, and K Itoh, and K Utsumi, and M Kotani, and C Taya, and H Yonekawa, and H Sakuraba
Department of Clinical Genetics, the Tokyo Metropolitan Institute of Medical Science, 18-22, Honkomagome-3, Bunkyo-ku, Tokyo 113-8613, Japan.

Human lysosomal alpha-galactosidase predominantly hydrolyzes ceramide trihexoside. A transgenic mouse line, C57BL/6CrSIc-TgN(GLA) 1951 Rin, highly expressing human alpha-galactosidase, has been established and investigated biochemically and immunohistochemically in order to clarify the distribution of the expressed enzyme proteins and to evaluate it as a donor model of organ transplantation therapy for Fabry disease caused by a genetic defect of alpha-galactosidase. In these transgenic mice, about five copies of the transgene were integrated, and alpha-galactosidase activity was expressed in liver, kidney, heart, spleen, small intestine, submaxillary gland, skeletal muscle, cerebrum, cerebellum, bone marrow cells and serum. The enzyme activity was about 22 to 11,080-fold higher than that in non-transgenic mice. In liver, heart and kidney tissues, which are important organs for transplantation studies, sufficient amounts of alpha-galactosidase mRNAs were transcribed, and the expressed enzymes, with molecular weights of 54-60 kDa, are abundant in the liver (enzyme activity: 53,965 nmol h-1 mg-1 protein) and heart (39,906 nmol h-1 mg-1 protein), followed by in the kidney tissue (9177 nmol h-1 mg-1 protein), respectively. An immunohistochemical microscopic study clearly demonstrated the distribution of the expressed enzyme proteins in kidney and liver tissues. Highly expressed alpha-galactosidase was detected in glomerular cells, tubular cells and hepatocytes. These transgenic mice will be useful as a donor model for experimental organ transplantation, and also it will enable recurrent biopsies and long-term observation. The organ transplantation data on mice will provide us with important information.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008247 Lysosomes A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the lysosome acts as a barrier between the enzymes enclosed in the lysosome and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured or undergoes MEMBRANE FUSION. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Autolysosome,Autolysosomes,Lysosome
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R Kase, and M Shimmoto, and K Itoh, and K Utsumi, and M Kotani, and C Taya, and H Yonekawa, and H Sakuraba
January 2008, Glycobiology,
R Kase, and M Shimmoto, and K Itoh, and K Utsumi, and M Kotani, and C Taya, and H Yonekawa, and H Sakuraba
February 1997, Rinsho byori. The Japanese journal of clinical pathology,
R Kase, and M Shimmoto, and K Itoh, and K Utsumi, and M Kotani, and C Taya, and H Yonekawa, and H Sakuraba
March 1996, Biochemical and biophysical research communications,
R Kase, and M Shimmoto, and K Itoh, and K Utsumi, and M Kotani, and C Taya, and H Yonekawa, and H Sakuraba
December 2020, International journal of molecular sciences,
R Kase, and M Shimmoto, and K Itoh, and K Utsumi, and M Kotani, and C Taya, and H Yonekawa, and H Sakuraba
December 2004, Pediatrics international : official journal of the Japan Pediatric Society,
R Kase, and M Shimmoto, and K Itoh, and K Utsumi, and M Kotani, and C Taya, and H Yonekawa, and H Sakuraba
February 2012, Genesis (New York, N.Y. : 2000),
R Kase, and M Shimmoto, and K Itoh, and K Utsumi, and M Kotani, and C Taya, and H Yonekawa, and H Sakuraba
February 2021, Neurobiology of disease,
R Kase, and M Shimmoto, and K Itoh, and K Utsumi, and M Kotani, and C Taya, and H Yonekawa, and H Sakuraba
November 1997, Annals of the New York Academy of Sciences,
R Kase, and M Shimmoto, and K Itoh, and K Utsumi, and M Kotani, and C Taya, and H Yonekawa, and H Sakuraba
July 1995, The Tokai journal of experimental and clinical medicine,
R Kase, and M Shimmoto, and K Itoh, and K Utsumi, and M Kotani, and C Taya, and H Yonekawa, and H Sakuraba
October 1995, Research communications in molecular pathology and pharmacology,
Copied contents to your clipboard!